Microbot Medical (MBOT) Net Cash Flow (2010 - 2026)

Microbot Medical's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$56000.0 for Q1 2026.

• Quarterly Net Cash Flow fell 154.9% year-over-year to -$56000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $652000.0 (down 68.27% YoY) and the FY2025 annual result came in at $810000.0, up 25.39% from the prior year.
• Net Cash Flow was -$56000.0 for Q1 2026 at Microbot Medical, up from -$2.8 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $2.6 million in Q4 2024 and bottomed at -$6.2 million in Q4 2022.
• A 5-year average of -$1.2 million and a median of -$1.3 million in 2024 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2022 — Net Cash Flow plunged 9241.18% — and 2025, when it soared 232.07%.
• Microbot Medical's Net Cash Flow stood at -$6.2 million in 2022, then soared by 118.28% to $1.1 million in 2023, then jumped by 132.04% to $2.6 million in 2024, then sank by 205.65% to -$2.8 million in 2025, then surged by 97.99% to -$56000.0 in 2026.
• Business Quant data shows MBOT's Net Cash Flow at -$56000.0 in Q1 2026, -$2.8 million in Q4 2025, and $2.6 million in Q3 2025.